Emtriaxone SB 1000mg/500mg Injection
Marketer
Embiotic Laboratories Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Emtriaxone SB 1000mg/500mg Injection
The dual-component injectable medication, Emtriaxone SB (1000 mg/500 mg), combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed treatment schedule is crucial; premature cessation can compromise its effectiveness. Complete the full course, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate prompt emergency care. Inform your physician of all current medications before commencing treatment; this is especially important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration promote faster recovery. Your physician may order laboratory tests to monitor the medication's effects.
Uses of Emtriaxone SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Emtriaxone SB 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Emtriaxone SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Emtriaxone SB 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Emtriaxone SB 1000mg/500mg Injection works:
The injectable formulation Emtriaxone SB (1000 mg Ceftriaxone / 500 mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, by counteracting bacterial resistance enzymes, potentiates Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Emtriaxone SB 1000 mg/500 mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Emtriaxone SB (1000 mg/500 mg) is typically regarded as safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administering Emtriaxone SB 1000 mg/500 mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Emtriaxone SB 1000 mg/500 mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Emtriaxone SB 1000 mg/500 mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Emtriaxone SB 1000 mg/500 mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the dosage of Emtriaxone SB 1000 mg/500 mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Emtriaxone SB 1000mg/500mg Injection :
Should you forget a scheduled dose of Emtriaxone SB 1000 mg/500 mg Injection, seek advice from your physician.
Facts to Know About Emtriaxone SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently